Imperial Ginseng Products Ltd.
IGPFF
$0.0605
$0.010621.24%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -90.12% |
| Gross Profit | -- | -- | -- | -- | -150.92% |
| SG&A Expenses | -87.72% | -88.27% | -84.21% | -71.32% | -35.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -90.34% | -95.47% | -92.59% | -89.47% | -70.43% |
| Operating Income | 90.34% | 90.86% | 80.74% | 71.62% | -23.96% |
| Income Before Tax | -96.10% | -95.60% | -94.91% | -93.01% | 91.93% |
| Income Tax Expenses | -101.49% | -101.50% | -101.21% | -93.44% | 55.95% |
| Earnings from Continuing Operations | -94.30% | -93.53% | -92.73% | -92.85% | 107.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.30% | -93.53% | -92.73% | -92.85% | 107.90% |
| EBIT | 90.34% | 90.86% | 80.74% | 71.62% | -23.96% |
| EBITDA | 99.73% | 97.55% | 88.13% | 74.82% | -30.92% |
| EPS Basic | -94.33% | -93.50% | -92.72% | -92.79% | 102.55% |
| Normalized Basic EPS | 85.16% | 89.51% | 93.37% | 91.12% | 20.26% |
| EPS Diluted | -95.96% | -94.24% | -93.29% | -94.35% | 99.38% |
| Normalized Diluted EPS | 85.16% | 89.51% | 93.37% | 91.12% | 19.83% |
| Average Basic Shares Outstanding | 0.00% | 1.80% | 2.37% | 3.06% | 3.97% |
| Average Diluted Shares Outstanding | 0.00% | 1.80% | 2.37% | 3.06% | 3.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |